Mar 5, 2020
LSPediA has successfully completed the FDA DSCSA Pilot Program Project for Router Service Solution for Verification/Notification and Interoperability 2023. The pilot is participated by companies of between 200 to 20,000 employees who collectively represent the end-to-end Rx supply chain including manufacturer, wholesaler, and dispenser partners. Working in concert with Kowa, Ingenus, Auburn Pharma, AmerisourceBergen, Smith Drug, and SpartanNash, the pilot verified 20,000+ live serialized rx packages, accomplished the goals and objectives, and achieved several firsts in the industry. A final report was submitted to the FDA. The final report is available to download by request on lspedia.com.
(PRUnderground) March 5th, 2020

LSPediA today announced the company has successfully completed the FDA DSCSA Pilot Program Project, Router Service Solution for Verification/Notification and Interoperability 2023. Working with companies composed of between 200 to 20,000 employees, the pilot focused on end-to-end supply chain activities using the unique product identifier to perform verifications and interoperability.
The pilot achieved several firsts in the industry:
The most live serialized Rx packages verified – Over 20,000 packages are scanned and verified end to end in the supply chain by the unique Product Identifier. The most functional groups participated – Over 11 functional groups worked activities related to managing the serialized Rx. They represent production, warehouse, supply chain, quality, compliance, IT, customer service, accounting, pharmacy operations, corporate security, and reverse logistics. The most complete serialized supply chain demonstration with live inventory – Participants saw products moved end to end and learned the functions and usage of unique a Product Identifier beyond their four walls. The most complete verification scenarios – The pilot performed 10 verification scenarios covering returns, positive, negative, recall, suspect, counterfeit, illegitimate, theft, fraud, and phishing.The pilot participating companies who represented the end-to-end Rx supply chain are manufacturer, wholesaler, and dispenser partners. Working in concert with Kowa, Ingenus, Auburn Pharma, AmerisourceBergen, Smith Drug, and SpartanNash, LSPediA’s FDA Pilot Project successfully executed planned activities and accomplished goals and objectives proposed. A final report was submitted to the FDA and is available to download by request through LSPediA. The report provides a wealth of data, KPIs, and other information, summarized here:
4 process maps developed 7 participanting companies 10 verificaiton scenarios 15 participating prescription products in unit and case 22737 Rx packages scanned 17,287 serialized packages verified“First and foremost, we extend our appreciation to all of the participants,” said Riya Cao, LSPediA CEO. “Thanks to everyone who dedicated time and resources to create an environment that mimicked a production-like transaction pool of data and activity.”
The Pilot Project’s important findings and achievements include:
Testing the state-of-the-art OneScan software, including its Investigator module, which enables a collaborative and automated single-source-of-truth platform for product investigations An industry recommendation concerning undesirable labeling practices encountered in the product verification process Discovering that, based on warehouse inventory scans, a large number of “good” products are still failing verification due to barcode anomalies A readiness issue discovered during negative verification “fire drills,” which revealed SOP gaps including serialization and documentation, audit trails, etc. Products associated with manufacturers not using OneScan failed to return a verification response due to their solution providers not being enabled or in productionThe FDA will now spend time absorbing the comprehensive reporting and likely issue a report containing insights and industry guidance. For complete Pilot Program details, contact LSPediA.
About LSPediA Inc.
LSPediA provides SaaS solutions to the pharmaceutical industry. Manufacturers, wholesale distributors, dispensers, and healthcare providers partner with LSPediA to make, move, track, verify, and protect the drug products in their care for patient safety.
LSPediA is different because our solution potential is limitless. Built with user efficiency, automation, and data security at their core, our solutions are transforming compliance and supply chain efforts. LSPediA’s OneScan, RxChain, and Investigator technologies enable error-free and keyboard-free capabilities for ASN, EPCIS, VRS, issue tracking, and interoperability.
For more information about our capabilities, call +1 (248) 973-2008, email [email protected], or visit our website at www.lspedia.com.
About LSPediA Inc.
LSPediA provides SaaS solutions to the pharmaceutical industry. Manufacturers, wholesale distributors, dispensers, and healthcare providers partner with LSPediA to make, move, track, verify, and protect the drug products in their care for patient safety.
LSPediA is different because our solution potential is limitless. Built with user efficiency, automation, and data security at their core, our solutions are transforming compliance and supply chain efforts. LSPediA’s OneScan, RxChain, and Investigator technologies enable error-free and keyboard-free capabilities for ASN, EPCIS, VRS, issue tracking, and interoperability.
For more information about our capabilities, call +1 (248) 973-2008, email [email protected], or visit our website at www.lspedia.com.
Press Contact Name: Kevin Burcroff Phone: 248.973.2008 Email: [email protected] Website: https://www.lspedia.com
Original Press Release.
Artificial intelligence models will soon be powerful enough to master biology, presenting both benefits and serious risks, Tencent Holdings’ chief AI scientist and former OpenAI star researcher Vinces Yao Shunyu said during a rare public appearance on Saturday. The assessment comes as frontier AI systems are increasingly being applied to medicine and biology, which could accelerate discovery of new drugs and other treatments. However, experts also warn that malicious actors could use AI to...
Sony is building an anime empire, betting that global fandom can fuel growth for both the company and the country as foreign rivals and A.I. swarm the scene.
Humanoid robots represent the next frontier for Pudu Robotics, according to founder and CEO Felix Zhang Tao, as the global commercial robotics leader takes on Elon Musk’s Tesla in the growing sector and explores manufacturing in Europe, its largest overseas market. “It’s definitely a competitor, but a long-term one,” Zhang told the South China Morning Post in a recent interview, adding that Tesla was a “very good” rival whose high profile had driven innovation and broadened market awareness in...
Washington’s decision to upgrade Pakistan’s F-16 fighter jets has drawn accusations of double standards from critics in India, who question why the United States is strengthening a nuclear-armed ally while waging war against Iran over its nuclear programme. Although the US$686 million military modernisation package does not include nuclear weapons, analysts say that improvements to the fighter jets’ navigation, communications and survivability could boost Pakistan’s existing nuclear strike...
When Japan’s “symbol of affordability” Uniqlo decided to increase the price of its basic socks last month, it sparked a backlash before the clothing titan made an immediate U-turn. That came after Italian-style family restaurant chain Saizeriya issued an almost grovelling apology as it decided to add 20 yen (US$0.13) to the price of its trademark Milanese Doria, lamenting its “lack of effort”. The very public angst, including in one of the world’s most recognisable clothing brands, highlights...
India’s top court decreed that only more environmentally friendly fireworks could be set off this weekend, citing air quality concerns. But environmental activists call it a “green wash.”
Food was at the heart of Henry Onesemo’s South Pacific island upbringing. Now, he’s bringing flavors of home to his Michelin-starred restaurant in New Zealand.
For most of his life, Osman Uki lived in a world dictated by the sun, relying on kerosene and leftover cooking oil to light his home in a remote indigenous village in Malaysia. That changed in April when solar power finally reached Kampung Bertang in the state of Pahang, allowing families to power electric lights, refrigerators and rice cookers. For Osman, one of the biggest changes is what happens after sunset. “We are happy with the light we have at night. The kids can read at night now. We...
Cooking and bathing became difficult when taps ran dry in Batam, an Indonesian island where residents are protesting against data centres springing up to power the global artificial intelligence boom. The area had suffered a “long drought” caused by low rainfall, the local water utility operator said, as a strong El Nino cycle exacerbates dry weather. But, as in other countries, anger has been directed at the data centres, warehouse-like facilities that keep apps and AI tools running, with water...
Long before Moe Harukawa was killed, she lived in fear. The 21-year-old shop assistant had reported her ex-boyfriend to police and a court had ordered him to stay away from her. Yet weeks later, Taiki Hirokawa, 26, walked into Harukawa’s workplace – a packed Pokemon store in Tokyo’s Ikebukuro district – and stabbed her repeatedly in the neck and torso before turning the knife he was carrying on himself. Both later died in hospital. Harukawa’s gruesome murder in March at the hands of a man who...
When her prescription for Mounjaro became too expensive, Bey* did what a growing number of Malaysians are doing: she found a cheaper vial online. The 34-year-old from Kuala Lumpur started on the weight-loss drug about a year ago and hasn’t looked back since. “I didn’t feel like eating, I didn’t feel hungry,” she said, recalling flying to Jakarta for a “food trip” recently during which she barely ate. Reviews on Threads and TikTok led her to online sellers offering “tirzepatide”, Mounjaro’s...
The contest to replace António Guterres as U.N. secretary general has been jolted by last-minute entrants and deep divisions among members of the Security Council.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.